Pharmacomicrobiomics in Psoriasis: Microbiome–Drug Interactions Across Systemic Treatments
Psoriasis is a chronic immune-mediated skin disease with highly variable responses to systemic therapies. Emerging evidence highlights the microbiome as a potential modulator of drug efficacy and toxicity. Gut bacteria can enzymatically metabolize drugs, such as methotrexate, altering bioavailabilit...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI AG
2026-03-01
|
| Serier: | Life |
| Fag: | |
| Online adgang: | https://www.mdpi.com/2075-1729/16/3/415 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
